MRI Surveillance Replaces Prophylactic Cranial Irradiation for SCLC

For decades, clinicians relied on prophylactic cranial irradiation (PCI) to prevent brain metastases, despite the procedure's known potential for cognitive decline. The MAVERICK study, which enrolled 304 patients between 2020 and 2025, sought to determine if modern, frequent MRI monitoring could offer a safer alternative. Participants were randomized to receive either MRI surveillance alone or the combination of MRI and PCI, with both groups undergoing rigorous cognitive testing every three to six months.

At a median follow-up of 22 months, the data showed that the surveillance-only strategy significantly preserved cognitive function without compromising survival outcomes. While overall survival rates remained comparable between the two groups, the incidence of serious treatment-related adverse events was starkly different: only 0.8% of patients in the surveillance arm experienced grade 3–5 adverse events, compared to 7.9% in the PCI group. Dr. Chad Rusthoven of the University of Colorado School of Medicine noted that these benefits held consistent across both limited-stage and extensive-stage disease, reinforcing the move toward a less invasive standard of care.